ArticleNature communications2024

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy.

Xin Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.